Bay Area Biotech on 12/6 →
January 27th, 2010
(Page 4 of 7)
Catalent Pharma Solutions
ChemRx Advanced Technologies
Dow Agro Sciences
eBiochemica Solutions Pvt. Ltd.
Fqubed … Next Page »
Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at email@example.com or call (619) 669-8788 Follow @bvbigelow
By posting a comment, you agree to our terms and conditions.
there is a biology company-cd genomics. CD Genomics was established in 2004, we are aiming at providing the research community with high quality Next Generation Sequencing, high throughput microarray services. Due to the demand for our services has being increased; CD Genomics has already updated its technology platform to mainstream NGS and microarray instruments. At present, our senior bioinformaticians have ever viewed more than ten thousands of trace files and accumulated abundant experience with our Illumina HiSeq2000/2500, Illumia Miseq, Ion Torrent PGM, PacBio RS and ABI 3730/3730XL analyzers. We continue to work hard to offer you the same dependable services to pharmaceutical and biotech companies, as well as academia and government agencies for the purpose of satisfying all your sequencing or array needs.
cd genomics(www.cd-genomics.com) is focusing on dna sequeincing, microarray and so on.
Sponsored · Whitepaper
Moreover, more than half of Fortune 500 pharmaceutical and medica
Xconomy Insight · Special Report
Success or failure depends on you. Get advice from the experts to help your startup succeed
Reduce turnaround times, cut excessive admin expenses and increas
A global survey of clinical professionals reveals unique insights
The state’s programs for entrepreneurs made a record-setting impact in 2016.
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2017, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.